Rhythm Pharmaceuticals wins FDA approval to expand IMCIVREE use to acquired hypothalamic obesity in adults and children 4+
https://finviz.com/quote.ashx?t=RYTM&p=d
Rhythm Pharmaceuticals wins FDA approval to expand IMCIVREE use to acquired hypothalamic obesity in adults and children 4+
https://finviz.com/quote.ashx?t=RYTM&p=d
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.